Cell death and IL-1β and IL-18 release were significantly decreased in either unprimed or IFN-γ-primed hMDMs treated with the pan-caspase inhibitor ZVAD prior to infection with T4SS+ Lp, compared to vehicle control-treated cells (Fig. 2A through C). Here, IL18 is linked to infection.